Her fellowship research focuses on functional imaging in psychogenic movement disorders and her PhD research focuses on Parkinson's disease and ... before PD onset, and dopamine agonist therapy ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

“Studies have shown that most people with Parkinson’s disease have lost 60-80% or more of the dopamine-producing ... signals in the brain motor pathways. This means hand tremors happen when ...

Dopamine, a key neurotransmitter in the brain, plays a vital role in functions like memory, attention, productivity, weight management, and curbing impulsive behavior. It is also crucial in preventing ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson's disease (PD). It is not known if ONAPGO is safe and effective in children. Do not ...

14, 2025 — There may be a link between hearing impairment and an increased risk of developing ... have linked disease-related proteins and genes to identify specific cellular pathways ...